Wanita kematian bayi mendapat pampasan
woman whose baby died due to negligence wins
compensation
KUALA
LUMPUR: A Saudi woman, whose baby died because of negligence at a private
hospital in the city nearly four years ago, has been awarded RM280,000 in
damages by the High Court here.
Turkyah
Abdul Rahman Assiri, 31, who studies at the International Islamic University of
Malaysia, was awarded RM200,000 in general damages and RM80,000 for pain and
suffering in her case against gynaecologist Dr Seri Suniza Sufian of Prince
Court Medical Centre.
Judicial
Commissioner Rosilah Yop, delivering her decision in chambers, also ordered Dr
Seri Suniza to pay the student RM25,000 in costs.
Turkyah and
her husband, a PhD student at Universiti Teknologi Mara (UiTM), are currently
back in Saudi for Ramadan. The baby in the suit was to have been their fourth
child.
Turkyah’s
lawyer Abdul Razak Hashim told reporters that the court made the order over the
damages after Dr Seri Suniza admitted liability on May 28 over medical
negligence in October 2010.
However, the
hospital, which had been also named a defendant, did not admit to negligence,
leading to the charge against it to be withdrawn.
“The doctor
admitted to liability and the judicial commissioner held that she was fully
responsible over the action,” said Abdul Razak, adding that it led to the
removal of Turkyah’s uterus and left her unable to ever conceive again.
He later told The Star that Turkyah and her
husband were in court when the doctor admitted liability.
In her
statement of claim filed on Jan 6, Turkyah said Dr Seri Suniza was negligent in
administering Cytotec 100mcg to induce labour during delivery on Oct 16, 2010.
Abdul Razak
said the baby was stillborn due to the use of the drug.
According to
court papers, the drug, registered with the Drug Control Authority of Malaysia,
was for the healing of duodenal and gastric ulcers.
In 2003, the
Health Ministry wrote to the Malaysian Medical Association and the Association
of Private Hospitals to warn against using the drug to induce labour.
In 2012, the
ministry’s pharmaceutical services division said the usage of the drug could
lead to uterine rupture in patients with previous Caesarean section scars.
No comments:
Post a Comment
Note: only a member of this blog may post a comment.